Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
With a market cap of 358.7B, Merck(MRK) trades at $145.31. The stock has a price-to-earnings ratio of 119.32 and currently yields dividends of 2.25%.
On 2026-10-01, Merck(MRK) stock traded between a low of $145.17 and a high of $149.30. Shares are currently priced at $145.31, which is +0.1% above the low and -2.7% below the high.
Merck(MRK) shares are trading with a volume of 10.23M, against a daily average of 11.58M.
During the past year, Merck(MRK) stock moved between $78.40 at its lowest and $156.92 at its peak.
During the past year, Merck(MRK) stock moved between $78.40 at its lowest and $156.92 at its peak.
MRK News
shares have climbed sharply in recent years, so the live question is whether the current price is still in line with the cash the business is expected to genera...
In the latest close session, Merck (MRK Quick QuoteMRK - Free Report) was down 2.66% at $145.31. The stock fell short of the S&P 500, which registered a l...
Merck & Co Inc. (NYSE:MRK) on Wednesday presented initial results from its Phase 2b MK-7240-012 trial at the European Academy of Dermatology and Venereology (EA...
Analyst ratings
68%
of 31 ratingsMore MRK News
After Merck (MRK) presented Phase 2b data for tulisokibart in moderate-to-severe hidradenitis suppurativa at the EADV Congress and reported that it met the prim...
Merck (MRK) on Wednesday announced that it succeeded in a mid-stage trial for tulisokibart, its experimental therapy for an inflammatory skin condition known as...
Merck (MRK) announced the first presentation of results from MK-7240-012, a Phase 2b multicenter, randomized, double-blind, placebo-controlled trial evaluating...
Key Points SCHD holds several high-quality, high-yielding healthcare dividend stocks. Johnson & Johnson and Medtronic aren't on its list of holdings. Its two...
Investing Merck Turned $1,000 Into $3,395 in a Decade but the Real Story Happened in the Last Year Merck spent most of a decade trailing the S&P 500, then somet...
Scotiabank raised the firm’s price target on Merck (MRK) to $180 from $155 and keeps an Outperform rating on the shares. The firm believes Merck’s products and...
Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of cou...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.